Zdrowie i gospodarka · 24/10/2022
FDA Releases Draft Guidance for Topical Dermatologic Corticosteroids Bioequivalence
The FDA has made available a draft guidance for industry on demonstrating the bioequivalence of topical dermatologic corticosteroids, aiming to assist applicants in submitting abbreviated new drug applications for these products, replacing the 1995 guidance
Source: Federal Register — Food and Drug AdministrationOpen original release →